| 中文名称 | 莫索尼啶 |
|---|---|
| 中文别名 | 莫索尼啶;4-氯-N-(4,5-二氢-1H-咪唑-2-基)-6-甲氧基-2-甲基-5-嘧啶胺;莫索尼定,不带盐酸,;莫索尼定;[ 2,4,6 -13C3 ] - 莫索尼定标准品;4-氯-N-(4,5-二氢-1H-咪唑-2-基);Moxonidine 莫索尼啶;莫索尼定 EP标准品;莫索尼定-D3;特索芬辛 |
| 英文名称 | Moxonidine |
| 英文别名 | Moxonidine;MOXONIDINE HCL;4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin;bdf5895;be5895;BDF-5895 HCL;4-CHLORO-6-METHOXY-2-METHYL-5-(2-IMIDAZOLIN-2-YL)AMINOPYRIMIDINE HCL;4-CHLORO-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-6-METHOXY-2-METHYL-5-PYRIMIDINAMINE HYDROCHLORIDE;2-METHYL-5-AMINO-4,6-DICHLORO PYRIMIDINE;4-chloro-6-methoxy-2-methyl-5-(2-imidazolin-2-yl)-aminopyrimidine;4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methylpyrimidin-5-amine;4-Chloro-N-imidazolidin-2-ylidene-6-methoxy-2-methylpyrimidin-5-amine;[14C]-Moxonidine;[3H]-Moxonidine;4-chloro-5-(imidazoline-2-ylamino)-6-methoxy-2-methylpyrimidine;4-chloro-5-[(4,5-dihydro-1H-imidazol-2-yl)-amino]-6-methoxy-2-methylpyrimidine;4-chloro-N-(4,5-dihydro-1H9imidazol-yl)-6-methoxy-2-methyl-5-pyrimidinamine;4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine;Cynt;Lomox;Moxonidinum [Latin];Norcynt;Normoxocin;Nucynt;Physiotens;2-(6-Chloro-4-methoxy-2-methylpyrimidin-5-ylamino)-2-imidazoline;LY 326869;Moxon;BDF 5895;BE 5895;EN300-7360649;MFCD22689455;AB00514003-08;UNII-CC6X0L40GW;4-chloro-N-(imidazolidin-2-ylidene)-6-methoxy-2-methylpyrimidin-5-amine;MLS002222183;Moxonidine (USAN/INN);Prestwick2_001016;HMS1571K13;PDSP2_000176;SDCCGSBI-0050731.P002;NCGC00015649-01;Prestwick0_001016;HY-B0374;1008754-16-2;NCGC00015649-02;Cynt (TN);Moxonidina [Spanish];4-chloro-N-(imidazolin-2-ylidene)-6-methoxy-2-methyl-5-pyrimidinamine;Moxonidine [USAN:INN:BAN];Monoxidine [common misspelling of Moxonidine];CHEMBL19236;DTXCID3025170;Moxonidine; 4-Chloro-N-(imidazolidin-2-ylidene)-6-methoxy-2-methylpyrimidin-5-amine;D05087;4-Chloro-5-(2-imidazolidinyldeneamino)-6-methoxy-2-methylpyrimidine;HMS3747A03;Moxonidine hydrochloride hydrate;AB00514003_10;SR-01000075981-7;HMS2230B15;A838414;SW196502-4;SPBio_003042;NCGC00015649-04;Moxonidinum;Moxonidine [INN];MOXONIDINE [MI];2-(4-Chloro-6-methoxy-2-methyl-pyrimidin-5-ylamino)-4,5-dihydro-3H-imidazol-1-ium;NCGC00015649-17;Prestwick1_001016;NS00007154;FT-0657360;BDF-5895;AB00514003;PDSP1_000177;Q419944;5-Pyrimidinamine, 4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-;HMS3373O04;CCG-204838;FT-0601601;GTPL12574;SR-01000075981;CAS-75438-57-2;BPBio1_001289;C07451;BDBM50050093;NCGC00015649-05;Moxonidina;HMS2098K13;4-Chloro-5-(2-imidazolin-2-ylamino)-6-methoxy-2-methylpyrimidine;CHEBI:7009;AKOS015997932;MOXONIDINE [USAN];M2660;DTXSID5045170;Tox21_110190_1;AKOS015895873;BCP23003;DB09242;MOXONIDINE [EP MONOGRAPH];75438-57-2;BRD-K77771411-001-04-4;s2066;Prestwick3_001016;5-Pyrimidinamine, 4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl- (9CI);4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-pyrimidin-5-amine hydrochloride;Moxonidine;MOXONIDINE [MART.];MOXONIDINE [WHO-DD];BDF5896;SMR000857402;NCGC00092355-02;AC-637;BSPBio_001171;NCGC00015649-08;BDF-5896;Lopac-M-1559;4-chloro-6-me... |
| CAS No. | 75438-57-2 |
| 分子式 | C9H12ClN5O |
| 分子量 | 241.68 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学